Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Nanostructures for Drug Delivery to the Brain

Author(s): L. Martin-Banderas, M. A. Holgado, J. L. Venero, J. Alvarez-Fuentes and M. Fernandez-Arevalo

Volume 18 , Issue 34 , 2011

Page: [5303 - 5321] Pages: 19

DOI: 10.2174/092986711798184262

Price: $65

Abstract

This review aims to summarize present approaches employed in delivering drugs to the central nervous system. Changes in blood-brain barrier (BBB) function have been reported in several neurological disorders. A brief description of the blood brain barrier and the main pathologies related to this barrier disfunction are described. Treatments for these disorders are based on several available strategies for delivering drugs into the brain, through circumvention of the BBB, as disruption of the BBB, prodrugs, molecular Trojan horses, among others. Particular attention will be placed on nanocarriers and more specifically on polymeric nanoparticles, which are presented as the most promising strategy for CNS delivery, helping drugs to be targeted more efficiently to the brain. This also allows attacking previously untreatable disorders such as brain tumors and other neurodegenerative diseases. New strategies and technologies commercialized by different pharmaceutical companies are also included.

Keywords: Blood-brain barrier, brain targeting, CNS delivery, drug delivery, nanocarriers, nanostructures, polymeric nanoparticles, neurodegerative diseases, brain tumors, BBB disfunction


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy